LINC01352: A Potential Drug Target and Biomarker (G101929730)

Target Name: LINC01352

NCBI ID: G101929730

LINC01352

Other Name(s): long intergenic non-protein coding RNA 1352 | Long intergenic non-protein coding RNA 1352

LINC01352: A Potential Drug Target and Biomarker

LINC01352 is a long intergenic non-protein coding RNA (lncRNA) with a length of approximately 290 nucleotides. It is located between the genes P09 and P10 on chromosome 16 and is expressed in various tissues and cells of the human body.

Recent studies have identified LINC01352 as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and mental health conditions.

One of the reasons for the potential drug target status of LINC01352 is its expression in various tissues and cells, which suggests that it may be involved in the development and progression of several diseases. Additionally, its expression has been correlated with the expression of several proteins that are known to be involved in disease development, such as the and.

Another potential drug target for LINC01352 is its expression in the brain, where it has been shown to be expressed in various brain regions and to be involved in the development and progression of several neurological diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its potential drug target and biomarker properties, LINC01352 has also been shown to have several potential functions in the body. For example, it has been shown to play a role in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. Additionally, LINC01352 has been shown to be involved in the regulation of cell cycle progression, which is important for the growth and division of cells.

Overall, LINC01352 is a promising candidate for drug targeting and biomarker research. Further studies are needed to fully understand its functions and potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1352

The "LINC01352 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01352 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets